Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer

Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer

Triple-negative breast cancer (TNBC) is insensitive to endocrine and Her2-directed therapies, making the development of TNBC-targeted therapies an unmet medical need. Since patients with TNBC frequently show a quicker relapse and metastatic progression compared to other breast cancer subtypes, we hy...

Full description

Bibliographic Details
Main Authors: Roberto Ruiu, Giuseppina Barutello, Maddalena Arigoni, Federica Riccardo, Laura Conti, Giulia Peppino, Laura Annaratone, Caterina Marchiò, Giulio Mengozzi, Raffaele Adolfo Calogero, Federica Cavallo, Elena Quaglino
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
cancer stem cell (CSC)
triple negative breast cancer (TNBC)
transcriptomics
teneurin 4 (TENM4)
Online Access:https://www.mdpi.com/2072-6694/13/4/894

Internet

https://www.mdpi.com/2072-6694/13/4/894

Similar Items